| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1996;111:815-826
© 1996 Mosby, Inc.
GENERAL THORACIC SURGERY |
Received for publication April 27, 1995 Revisions requested July 17, 1995; revisions received August 7, 1995 Accepted for publication Sept. 15, 1995. Address for reprints: Valerie W. Rusch, MD, Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
Abstract
Objectives: Progress in the therapy of malignant pleural mesothelioma is limited by the lack of an adequate staging system and controversy about prognostic factors. This surgical series was analyzed to determine whether a new TNM staging system proposed by the International Mesothelioma Interest Group and certain prognostic factors could stratify patients in future clinical trials. Methods: Thoracotomy was performed if computed tomographic scans showed resectable tumor confined to one hemithorax. Pleurectomy/decortication was done if visceral pleural tumor was minimal, and extrapleural pneumonectomy was done for more locally advanced disease. Complete resection was defined as no gross residual tumor. Adjuvant therapy was given as required by serial clinical trials. Patients had computed tomographic scans every 3 months until death. Prognostic factors were examined by log-rank and Cox regression analyses. Results: From October 1983 to July 1994, a total of 131 thoracotomies were performed, resulting in 101 resections, 72 of which were complete. Extrapleural pneumonectomy was done in 50 patients and pleurectomy/decortication in 51. The ratio of men to women was 108:23. Median age was 63 years (range 32 to 80 years). Operative mortality was five of 131 patients (3.8%), three of 50 in the group having extrapleural pneumonectomy (6%). Ninety-five of the 131 tumors were epithelial. Fifty-one of 89 patients (57%) having node dissections had diseased nodes, 45 (50%) N2. By univariate analysis, type of resection, T and N status, stage, histologic type, and adjuvant therapy, but not gender or age, significantly affected survival. Type of resection, stage, and histologic type were significant in a multivariate analysis. Local recurrence occurred mainly after pleurectomy/decortication, and distant metastases developed after extrapleural pneumonectomy. Conclusions: (1) N2 nodal disease is more frequent than previously reported; (2) the prognostic importance of histologic type is confirmed; (3) both T and N status influence outcome, and the International Mesothelioma Interest Group staging system successfully identifies patients whose prognosis is poor; (4) despite more locally advanced disease in most patients with extrapleural pneumonectomy, that approach provided better local control than pleurectomy/decortication but failed to improve survival because of distant metastatic disease. Contrary to past practice, future clinical trials should stratify for histologic type, must control for TNM stage, and must consider the impact of type of surgical resection on the pattern of relapse. (J THORAC CARDIOVASC SURG1996;111:815-26)
This article has been cited by other articles:
|
|
 |
|
  J. B. Sorensen, J. Ravn, A. Loft, J. Brenoe, A. K. Berthelsen, and on behalf of the Nordic Mesothelioma Group Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 1090 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Flores, T. Routledge, V. E. Seshan, J. Dycoco, M. Zakowski, Y. Hirth, and V. W. Rusch The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the American Joint Committee on Cancer staging system J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. M. Abdel Rahman, R. M. Gaafar, H. A. Baki, H. M. El Hosieny, F. Aboulkasem, E. G. Farahat, A. M. Nouh, and K. A. Mansour Prevalence and pattern of lymph node metastasis in malignant pleural mesothelioma. Ann. Thorac. Surg., August 1, 2008; 86(2): 391 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakas, A. E. Martin Ucar, J. G. Edwards, and D. A. Waller The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 83 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Martin-Ucar, A. Nakas, J. G. Edwards, and D. A. Waller Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 765 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Perrot, K. Uy, M. Anraku, M. S. Tsao, G. Darling, T. K. Waddell, A. F. Pierre, A. Bezjak, S. Keshavjee, and M. R. Johnston Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aelony Staging in Malignant Mesothelioma Ann. Thorac. Surg., December 1, 2006; 82(6): 2337 - 2337. [Full Text] [PDF]
|
|
|
|
|
|
J. G. Edwards, D.J. Stewart, A. Martin-Ucar, S. Muller, C. Richards, and D. A. Waller The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 981 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rice, J. J. Erasmus, C. W. Stevens, A. A. Vaporciyan, J. S. Wu, A. S. Tsao, G. L. Walsh, S. G. Swisher, W. L. Hofstetter, N. G. Ordonez, et al. Extended Surgical Staging for Potentially Resectable Malignant Pleural Mesothelioma Ann. Thorac. Surg., December 1, 2005; 80(6): 1988 - 1993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Pass, D. Lott, F. Lonardo, M. Harbut, Z. Liu, N. Tang, M. Carbone, C. Webb, and A. Wali Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N. Engl. J. Med., October 13, 2005; 353(15): 1564 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Erasmus, M. T. Truong, W. R. Smythe, R. F. Munden, E. M. Marom, D. C. Rice, A. A. Vaporciyan, G. L. Walsh, B. S. Sabloff, L. D. Broemeling, et al. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hazarika, R. M. White Jr., B. P. Booth, Y.-C. Wang, D. Y. Lee Ham, C. Y. Liang, A. Rahman, J. V.S. Gobburu, N. Li, R. Sridhara, et al. Pemetrexed in Malignant Pleural Mesothelioma Clin. Cancer Res., February 1, 2005; 11(3): 982 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hazarika, R. M. White, J. R. Johnson, and R. Pazdur FDA Drug Approval Summaries: Pemetrexed (Alimta(R)) Oncologist, September 1, 2004; 9(5): 482 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Stewart, A. Martin-Ucar, J. E. Pilling, J. G. Edwards, K. J. O'Byrne, and D. A. Waller The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma Ann. Thorac. Surg., July 1, 2004; 78(1): 245 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.E. Pilling, D.J. Stewart, A.E. Martin-Ucar, S. Muller, K.J. O'Byrne, and D.A. Waller The case for routine cervical mediastinoscopy prior to radical surgery for malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 497 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Parker and E Neville Lung cancer * 8: Management of malignant mesothelioma Thorax, September 1, 2003; 58(9): 809 - 813. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Flores, T. Akhurst, M. Gonen, S. M. Larson, and V. W. Rusch Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 11 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Aziz, A. Jilaihawi, and D. Prakash The management of malignant pleural mesothelioma; single centre experience in 10 years Eur. J. Cardiothorac. Surg., August 1, 2002; 22(2): 298 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Mikulski, J. J. Costanzi, N. J. Vogelzang, S. McCachren, R. N. Taub, H. Chun, A. Mittelman, T. Panella, C. Puccio, R. Fine, et al. Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma J. Clin. Oncol., January 1, 2002; 20(1): 274 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Rusch, K. Rosenzweig, E. Venkatraman, L. Leon, A. Raben, L. Harrison, M. S. Bains, R. J. Downey, and R. J. Ginsberg A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 788 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
British Thoracic Society Standards of Care Committ Statement on malignant mesothelioma in the United Kingdom Thorax, April 1, 2001; 56(4): 250 - 265. [Full Text]
|
|
|
|
|
|
G. Maggi, C. Casadio, R. Cianci, O. Rena, and E. Ruffini Trimodality management of malignant pleural mesothelioma Eur. J. Cardiothorac. Surg., March 1, 2001; 19(3): 346 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J G Edwards, K R Abrams, J N Leverment, T J Spyt, D A Waller, and K J O'Byrne Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems Thorax, September 1, 2000; 55(9): 731 - 735. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Schneider, C. Clary-Macy, S. Challa, K. C. Sasse, S. H. Merrick, R. Hawkins, G. Caputo, and D. Jablons Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 128 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.W. Grossebner, A.A. Arifi, M. Goddard, and A.J. Ritchie Mesothelioma - VATS biopsy and lung mobilization improves diagnosis and palliation Eur. J. Cardiothorac. Surg., December 1, 1999; 16(6): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Butchart Contemporary Management of Malignant Pleural Mesothelioma Oncologist, December 1, 1999; 4(6): 488 - 500. [Abstract] [Full Text]
|
|
|
|
|
|
V. W. Rusch and E. S. Venkatraman Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically Ann. Thorac. Surg., November 1, 1999; 68(5): 1799 - 1804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Sterman, L. R. Kaiser, and S. M. Albelda Advances in the Treatment of Malignant Pleural Mesothelioma Chest, August 1, 1999; 116(2): 504 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M B Jackson, D Pounder, C Price, A W Matthews, and E Neville Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma Thorax, March 1, 1999; 54(3): 238 - 241. [Abstract] [Full Text]
|
|
|
|
|
|
T. L. Moskal, T. J. Dougherty, J. D. Urschel, J. G. Antkowiak, A.-M. Regal, D. L. Driscoll, and H. Takita Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up Ann. Thorac. Surg., October 1, 1998; 66(4): 1128 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. I. Pass, B. K. Temeck, K. Kranda, S. M. Steinberg, and I. R. Feuerstein Preoperative Tumor Volume Is Associated With Outcome In Malignant Pleural Mesothelioma J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 310 - 318. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Campbell Malignant Mesothelioma Ann. Thorac. Surg., May 1, 1997; 63(5): 1503 - 1505. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
